Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Fierce Pharma
Novo Nordisk
Rybelsus
diabetes
clinical trials
Eli Lilly
Flag link:
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
Investors Business Daily
Novo Nordisk
Ozempic
diabetes
obesity
Flag link:
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Flag link:
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Flag link:
In insulin resistance pact, Dewpoint adds Novo Nordisk to its pharma-rich pipeline
In insulin resistance pact, Dewpoint adds Novo Nordisk to its pharma-rich pipeline
Enpoints
Dewpoint Therapeutics
Novo Nordisk
diabetes
insulin resistance
condensates
Flag link:
Six-month Ozempic shortage mostly over after weight-loss craze drained supply
Six-month Ozempic shortage mostly over after weight-loss craze drained supply
Seattle Times, WA
Novo Nordisk
drug shortages
Ozempic
diabetes
weight loss
Flag link:
California takes another step forward in its insulin production with $50M investment
California takes another step forward in its insulin production with $50M investment
Endpoints
California
insulin
diabetes
Flag link:
Merck, Viatris agree to settle patent feud surrounding diabetes drugs
Merck, Viatris agree to settle patent feud surrounding diabetes drugs
Endpoints
Merck
Viatris
patents
diabetes
Januvia
Janumet
Flag link:
Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs
Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs
Endpoints
Sanofi
Lantus
insulin
diabetes
drug pricing
Eli Lilly
Novo Nordisk
Flag link:
Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly
Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly
BioSpace
insulin
diabetes
drug pricing
Eli Lilly
Novo Nordisk
Flag link:
Bayer study finds communication gap in managing chronic kidney disease in patients with type 2 diabetes
Bayer study finds communication gap in managing chronic kidney disease in patients with type 2 diabetes
Medical Marketing and Media
Bayer
diabetes
chronic kidney disease
healthcare providers
physicians
Flag link:
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly
Forbes
Novo Nordisk
drug pricing
insulin
diabetes
Eli Lilly
Flag link:
CRISPR/ViaCyte and Genprex Vie for First Diabetes Gene Therapy
CRISPR/ViaCyte and Genprex Vie for First Diabetes Gene Therapy
BioSpace
ViaCyte
CRISPR Therapeutics
Genprex
diabetes
gene therapy
Flag link:
Sanofi throws down $2.9B to acquire diabetes partner Provention Bio
Sanofi throws down $2.9B to acquire diabetes partner Provention Bio
Fierce Pharma
Sanofi
Provention Bio
M&A
diabetes
Flag link:
Eli Lilly kicks off consumer campaign for diabetes drug Mounjaro
Eli Lilly kicks off consumer campaign for diabetes drug Mounjaro
Medical Marketing and Media
Eli Lilly
Mounjaro
diabetes
DTC ads
Flag link:
Why does insulin cost so much? Big Pharma isn’t the only player driving prices
Why does insulin cost so much? Big Pharma isn’t the only player driving prices
Medical Marketing and Media
diabetes
insulin
drug pricing
Flag link:
8 Moments that Defined Diabetes Tech
8 Moments that Defined Diabetes Tech
Medical Devices and Diagnostics Industry
diabetes
Medtech
Medtronic
Sensionics
Verily
Embecta
DexCom
Apple
CMS
Abbott Labs
Flag link:
Abbott Scores a 'Long-Awaited Win' in Diabetes
Abbott Scores a 'Long-Awaited Win' in Diabetes
Medical Devices and Diagnostics Industry
Abbott Labs
diabetes
Medtech
Freestyle Libre 2
FreeStyle Libre 3
FDA
Flag link:
Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance
Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance
CNBC
Eli Lilly
drug pricing
diabetes
insulin
Humalog
Humalin
Flag link:
Should Abbott and DexCom Investors Be Worried About Apple's Latest News?
Should Abbott and DexCom Investors Be Worried About Apple's Latest News?
Motley Fool
Medtech
diabetes
continuous glucose monitoring
Apple
DexCom
Abbott Labs
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »